Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance.


Journal

Journal of medical microbiology
ISSN: 1473-5644
Titre abrégé: J Med Microbiol
Pays: England
ID NLM: 0224131

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 7 2 2019
medline: 26 4 2019
entrez: 7 2 2019
Statut: ppublish

Résumé

We aimed to investigate the presence of three recently identified point mutations (A2115G, G2141A and A2144T) of the 23 S rRNA gene and compare them with the three most frequently encountered point mutations (A2142G, A2142C and A2143G) in Helicobacter pylori strains in Turkey. A total of 63 patients (mean 47.08±12.27) were included. The E-test method (for clarithromycin) was used for the clarithromycin antimicrobial susceptibility test of isolated H. pylori strains. Real-time PCR was used to detect the point mutations. A total of 24 out of 63 H. pylori strains (38.1%) were detected as clarithromycin resistant (>0.5 mg l We concluded that classical mutations of the 23 S rRNA gene resulted in higher clarithromycin MIC values than new mutations. These new point mutations caused moderate elevations in the MIC values of clarithromycin-resistant H. pylori strains.

Identifiants

pubmed: 30724729
doi: 10.1099/jmm.0.000944
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Ribosomal, 23S 0
Clarithromycin H1250JIK0A

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

566-573

Auteurs

Bekir Kocazeybek (B)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Merve Kutlu Sakli (MK)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Pelin Yuksel (P)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Mehmet Demirci (M)

Beykent University Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

Reyhan Caliskan (R)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Tevhide Ziver Sarp (TZ)

Eastern Mediterranean University, Faculty of Health Sciences, Nutrition and Dietetic Department, Famagusta, North Cyprus.

Suat Saribas (S)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Suleyman Demiryas (S)

Department of General Surgery, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Fatma Kalayci (F)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Huseyin Cakan (H)

Department of Microbiology, Istanbul University-Cerrahpasa, Institute of Forensic Sciences, Istanbul, Turkey.

Hayriye Kirkoyun Uysal (HK)

Istanbul University, Istanbul Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

Nesrin Gareayaghi (N)

Istanbul Sisli Hamidiye Etfal Training and Research Hospita, Blood Center, Istanbul, Turkey.

Sevgi Ergin (S)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Yusuf Ziya Erzin (YZ)

Department of Gastroenterology, Cerrahpasa Medical Faculty, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Kadir Bal (K)

Department of Gastroenterology, Cerrahpasa Medical Faculty, Istanbul University - Cerrahpasa, Istanbul, Turkey.

İhsan Tascı (İ)

Department of General Surgery, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Hrisi Bahar Tokman (HB)

Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH